Literature DB >> 27190093

Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients.

Holger Eggebrecht1, Maike Bestehorn2, Michael Haude3, Axel Schmermund4, Kurt Bestehorn5, Thomas Voigtländer4, Karl-Heinz Kuck6, Rajendra H Mehta7.   

Abstract

AIMS: Performing transcatheter aortic valve implantation (TAVI) at hospitals with only cardiology department but no cardiac surgery (CS) on-site is at great odds with current Guidelines. METHODS AND
RESULTS: We analysed data from the official, prospective German Quality Assurance Registry on Aortic Valve Replacement to compare characteristics and in-hospital outcomes of patients undergoing transfemoral TAVI at hospitals with (n = 75) and without CS departments (n = 22). An interdisciplinary Heart Team was established at all centres (internal staff physicians at hospitals with on-site CS; in-house cardiologists and visiting cardiac surgical teams from collaborating hospitals at non-CS hospitals). In 2013 and 2014, 17 919 patients (81.2 ± 6.1 years, 55% females, German aortic valve (GAV) score 2.0 5.6 ± 5.8%, logistic EuroSCORE I 21.1 ± 15.4%) underwent transfemoral TAVI in Germany: 1332 (7.4%) at hospitals without on-site CS department. Patients in non-CS hospitals were older (82.1 ± 5.8 vs. 81.1 ± 6.1 years, P < 0.001), with more frequent co-morbidities. Predicted mortality risks per GAV-score 2.0 (6.1 + 5.5 vs. 5.5 ± 5.9%, P < 0.001) and logEuroSCORE I (23.2 ± 15.8 vs. 21.0 ± 15.4%, P < 0.001) were higher in patients at non-CS sites. Complications, including strokes (2.6 vs. 2.3%, P = 0.452) and in-hospital mortality (3.8 vs. 4.2%, P = 0.396), were similar in both groups. Matched-pair analysis of 555 patients in each group with identical GAV-score confirmed similar rates of intraprocedural complications (9.2 vs. 10.3%, P = 0.543), strokes (3.2% for both groups, P = 1.00), and in-hospital mortality (1.8 vs. 2.9%, P = 0.234).
CONCLUSION: Although patients undergoing TAVI at hospitals without on-site CS department were older and at higher predicted perioperative death risk, major complications, and in-hospital mortality were not statistically different, suggesting the feasibility and safety of Heart Team-based TAVI at non-CS sites. These findings need confirmation in future randomized study. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Aortic stenosis; Complications; Conversion; Surgery; TAVI; TAVR

Mesh:

Year:  2016        PMID: 27190093     DOI: 10.1093/eurheartj/ehw190

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Transcatheter aortic valve implantation in Germany.

Authors:  Won-Keun Kim; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

2.  2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011.

Authors:  Gudrun Lamm; Matthias Hammerer; Uta C Hoppe; Martin Andreas; Rudolf Berger; Ronald K Binder; Nikolaos Bonaros; Georg Delle-Karth; Matthias Frick; Michael Grund; Bernhard Metzler; Thomas Neunteufl; Philipp Pichler; Albrecht Schmidt; Wilfried Wisser; Andreas Zierer; Rainald Seitelberger; Michael Grimm; Alexander Geppert
Journal:  Wien Klin Wochenschr       Date:  2021-03-23       Impact factor: 1.704

3.  Onsite cardiac surgery standby during transcatheter aortic valve implantation: when and why.

Authors:  Marco Vola; Antoine Gerbay
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: many questions still linger before a paradigm shift.

Authors:  Chiara Fraccaro; Giuseppe Tarantini
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Valvular Disease: Role of cardiac surgery support during contemporary TAVI.

Authors:  Torsten P Vahl; Susheel K Kodali
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

6.  Sex Differences in the Utilization and Outcomes of Surgical Aortic Valve Replacement for Severe Aortic Stenosis.

Authors:  Zakeih Chaker; Vinay Badhwar; Fahad Alqahtani; Sami Aljohani; Chad J Zack; David R Holmes; Charanjit S Rihal; Mohamad Alkhouli
Journal:  J Am Heart Assoc       Date:  2017-09-21       Impact factor: 5.501

Review 7.  A systematic review and meta-analysis of the cerebrovascular event incidence after transcatheter aortic valve implantation.

Authors:  Christian Frerker; Tobias Schmidt; Max M Meertens; Sascha Macherey; Sebastiaan Asselberghs; Samuel Lee; Jan Hendrik Schipper; Barend Mees; Ingo Eitel; Stephan Baldus
Journal:  Clin Res Cardiol       Date:  2022-03-17       Impact factor: 6.138

8.  A Glimpse into the Future: In 2020, Which Patients will Undergo TAVI or SAVR?

Authors:  Crochan J O'Sullivan; Peter Wenaweser
Journal:  Interv Cardiol       Date:  2017-05

9.  Minimally invasive surgical versus transcatheter aortic valve replacement: A multicenter study.

Authors:  Domenico Paparella; Giuseppe Santarpino; Pietro Giorgio Malvindi; Marco Moscarelli; Alfredo Marchese; Pietro Guida; Carmine Carbone; Renato Gregorini; Luigi Martinelli; Chiara Comoglio; Roberto Coppola; Alberto Albertini; Alberto Cremonesi; Armando Liso; Khalil Fattouch; Maria Avolio; Natale D Brunetti; Giuseppe Speziale
Journal:  Int J Cardiol Heart Vasc       Date:  2019-04-28

Review 10.  Current results and remaining challenges of trans-catheter aortic valve replacement expansion in intermediate and low risk patients.

Authors:  Alfonso Ielasi; Azeem Latib; Maurizio Tespili; Francesco Donatelli
Journal:  Int J Cardiol Heart Vasc       Date:  2019-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.